# Epimedin C enhances mitochondrial energy supply by regulating the interaction between MIC25 and UBC in rodent model

**Authors:** Mi Huang, Lei Yu, Zhong Li, Ying Wang, Chunlin Yang

PMC · DOI: 10.1371/journal.pone.0325031 · PLOS One · 2025-05-28

## TL;DR

Epimedin C improves muscle function by stabilizing a mitochondrial protein called MIC25, which helps maintain energy production and delay fatigue.

## Contribution

The study identifies a novel flavonoid pathway involving MIC25 and UBC that maintains mitochondrial function and enhances muscle performance.

## Key findings

- Epimedin C preserves mitochondrial function by stabilizing MIC25 through disruption of its interaction with UBC.
- MIC25 overexpression mimics the effects of Epimedin C, while its knockdown negates these benefits.
- Stabilization of MIC25 maintains cristae structure, improves ATP production, and delays muscle fatigue.

## Abstract

The study investigates the molecular mechanisms underlying the skeletal muscle-enhancing effects of Epimedin C, a natural flavonoid, focusing on its interaction with the mitochondrial cristae structural protein MIC25. Using C57BL/6 mice, we demonstrate that Epimedin C enhances exercise performance through preservation of mitochondrial function. Proteomic analysis identified MIC25 as a key protein modulated by Epimedin C, whose stability is regulated via ubiquitin-dependent degradation. Functional experiments revealed that Epimedin C disrupts the interaction between MIC25 and ubiquitin-conjugating enzyme C (UBC), preventing MIC25 degradation and maintaining the integrity of the mitochondrial contact site and cristae organizing system (MICOS). This stabilization preserves mitochondrial cristae structure, improves ATP production, and delays muscle fatigue. Notably, MIC25 overexpression mimicked Epimedin C’s effects, while its knockdown abolished these benefits. Our findings establish MIC25 as a critical effector of Epimedin C, elucidating a novel pathway through which flavonoids maintain mitochondrial homeostasis to enhance muscle function. These insights hold promise for developing therapies targeting muscle atrophy and metabolic disorders.

## Linked entities

- **Genes:** CHCHD6 (coiled-coil-helix-coiled-coil-helix domain containing 6) [NCBI Gene 84303], UBC (ubiquitin C) [NCBI Gene 7316]
- **Proteins:** CHCHD6 (coiled-coil-helix-coiled-coil-helix domain containing 6), UBC (ubiquitin C)
- **Chemicals:** Epimedin C (PubChem CID 5748394)

## Full-text entities

- **Genes:** Ubc (ubiquitin C) [NCBI Gene 22190] {aka 2700054O04Rik, Rps27a, TI-225, Uba52, Ubb}
- **Diseases:** muscle atrophy (MESH:D009133), metabolic disorders (MESH:D008659), muscle fatigue (MESH:D005221)
- **Chemicals:** Epimedin C (MESH:C106054), ATP (MESH:D000255), flavonoid (MESH:D005419)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rodentia (rodent, order) [taxon 9989]
- **Cell lines:** /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12119004/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12119004/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12119004/full.md

---
Source: https://tomesphere.com/paper/PMC12119004